Skip to content
JournalsWorldThe Global Research Discovery Platform
Login Sign Up

Academic Journal

Q3

Reumatologia

Termedia Publishing House Ltd.

PolandImmunology (Q3); Immunology and Allergy (Q3); Rheumatology (Q3)ISSN-matched source record
Submission information ↗
Q3Ranking
—Impact Factor (year unverified)
33H-index (SCImago 2025)
0.62SJR (2025)
1960-1961, 1963-2025Coverage

About Reumatologia

About Reumatologia

Reumatologia is a peer-reviewed scholarly journal published by 2860 (Poland). It focuses on Q3. Publication coverage spans 1960-1961, 1963-2025.

Key indicators: ISSN 0034-6233, 2084-9834; H-index 33.

Understanding This Journal's Metrics

Journal metrics help researchers assess fit, but they must be interpreted in context:

  • H-index (33): 33 articles have each received at least 33 citations, indicating growing recognition.

Publishing in Reumatologia

When considering this journal, verify its current indexing status, editorial board, and recent publications to ensure it meets your needs for visibility and credibility.

  • Scope fit: Confirm your research aligns with Q3. Off-scope manuscripts are typically desk-rejected quickly.
  • Author guidelines: Follow formatting, reference style, and article-type requirements exactly — non-compliant manuscripts may be returned without review.

Is This Journal Right for Your Paper?

  • Audience match: Will the journal's readers cite and build on your findings?
  • Timeline: Higher-tier journals mean longer review and higher rejection risk. Balance prestige against your schedule.
  • Indexing: Confirm indexing in Web of Science, Scopus, and PubMed (if biomedical) meets your institutional requirements.
  • Open access needs: Check funder mandates and whether the journal offers compliant OA options.

Frequently Asked Questions

What is the ISSN of Reumatologia?
0034-6233, 2084-9834.

Who publishes Reumatologia?
2860.

What are Reumatologia's metrics?
H-index 33.

Is Reumatologia peer-reviewed?
Yes — it is a peer-reviewed scholarly journal indexed in major academic databases.

Open-access policies and author information

Reported in the official DOAJ public CSV snapshot (2026-09-01), downloaded 2026-10-03. Record updated 2026-07-23. This snapshot does not establish today’s listing status or fee quotation.

Accepted manuscript languagesEnglish
Licence optionsCC BY-NC-SA
Peer-review processDouble anonymous peer review
APCDOAJ-reported APC: 200 EUR; 850 PLN
Waiver policy reportedYes
Other fees reportedNo
Author retains unrestricted copyrightNo
Digital preservationPMC
Reported submission-to-publication time10 weeks on average; not a guarantee
Openly licensed content since2005 (not the journal founding year)

Publisher policy links recorded by DOAJ

Source: DOAJ journal record. Journal metadata is distributed by DOAJ under CC0. Confirm current fees, tax, eligibility and waiver terms with the publisher.

Source-backed journal facts

ISSN(s)0034-6233, 2084-9834
ISSN-L0034-6233
Source typeJournal
Publisher / hosting organisationTermedia Publishing House
Publisher country codePL
Fully open access (OpenAlex)Yes
DOAJ flag (OpenAlex)Listed in OpenAlex metadata; confirm current status in DOAJ
Works recorded in OpenAlex1,690
Citations recorded in OpenAlex9,047
OpenAlex H-index39
Years represented in OpenAlex1986–2026 (not the founding or closing dates)

Topics in published research

Rheumatoid Arthritis Research and Therapies; Systemic Lupus Erythematosus Research; Systemic Sclerosis and Related Diseases; Spondyloarthritis Studies and Treatments; Autoimmune and Inflammatory Disorders Research; Inflammatory Myopathies and Dermatomyositis.

OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.

Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.

Found incorrect or outdated information?Help us keep this profile accurate.
Suggest an Edit